Dr. Guadalupe Janette Furuzawa Carballeda is a pharmaceutical chemist and biologist specializing in biochemistry and microbiology. She graduated from the School of Chemistry at the National Autonomous University of Mexico (UNAM). She earned a master’s degree in Basic Biomedical Research in Immunology and a Ph.D. in Cell Biology from the Institute of Biomedical Research at UNAM.
Since 2001, she has served as a Level D Medical Sciences Researcher at the Salvador Zubirán National Institute of Medical Sciences and Nutrition, where she has conducted ongoing scientific research and participated in various collaborative research projects. Since May 2021, she has been a Level D research professor in the School of Health Sciences at the Universidad Panamericana. She is classified as Level 3 in the SNII.
Throughout her more than 30-year career, Dr. Furuzawa Carballeda has made fundamental contributions to the study of the mechanisms of inflammation, immune regulation, and autoimmunity, notably through the development of clinically effective modified extracellular matrix molecules for the modulation of inflammatory processes. This innovative work has resulted in 21 national and international patents.
It has developed a drug based on collagen-polyvinylpyrrolidone that modulates chronic joint inflammation, enabling the safe and effective modification of the progression of osteoarthritis, one of the leading chronic degenerative diseases. The corresponding clinical studies have a level of evidence of 1a (IMSS Clinical Practice Guideline 32910), which has allowed for its inclusion in the Basic Health Sector List (Group N20; codes 00.000.3999.00 and 010.000.3999.01).
His academic output includes more than 100 scientific publications indexed in PubMed, book chapters, and presentations at national and international conferences. He has received numerous awards, including the National Chamber of the Pharmaceutical Industry (CANIFARMA) Award in 2006, 2022, and 2023; the “Dr. Roberto Kretschmer Schmid” Award from the National Academy of Medicine in 2011, 2014, and 2017; and the “Eduardo Liceaga” Award in 2020.
Finally, his commitment to training professionals stands out, as he has contributed to the academic education of undergraduate students and at least 18 graduate and specialty students, as well as medical interns.
Research Areas
- Identification of the mechanisms underlying inflammation (Th17, Th22, and Th9), immune regulation (Tregs, Bregs, and pDCregs), and autoimmunity
- Development of clinically effective modified extracellular matrix molecules for the modulation of inflammatory processes (rheumatoid arthritis and osteoarthritis)
- Assessment of Peripheral Tolerance in Autoimmune Diseases
- Evaluation of the pathophysiological mechanisms (genotyping, immunophenotyping, proteomics, etc.) of achalasia